Extendicare Price Target Boosted to C$39.00 by Royal Bank Of Canada

Financial analysts at Royal Bank Of Canada have raised their price target for Extendicare (TSE:EXE) to C$39.00, a potential upside of 18.83% from its previous close.

The firm currently has an 'outperform' rating on the stock and joins other research analysts who have also increased their price targets for EXE in recent weeks.

TD raised its target from C$32.00 to C$39.00, while National Bank Financial boosted theirs from C$34.00 to C$40.00.